MLZ.F

Healthcare Drug Manufacturers - Specialty & Generic

MediPharm Labs Corp.

€0.04

+0.00 +4.23% today

Price History

Not enough data

Key Stats

Market Cap

15.81M

Avg Volume

EPS

-€0.01

52W High

€0.05

52W Low

€0.03

Div. Yield

0.0%

Valuation

P/B Ratio

0.72

P/S Ratio

0.38

EV/EBITDA

-2.14

EV/Revenue

0.13

Margins

Gross Margin 31.7%

Operating Margin 0.8%

Net Margin (12.0%)

EBITDA Margin (5.8%)

Growth & Returns

Revenue Growth (YoY)

(15.4%)

Return on Equity

(13.2%)

Return on Assets

(5.2%)

Liquidity & Leverage

Current Ratio

2.69

Quick Ratio

1.68

Debt / Equity

0.01

Total Cash

10.42M

Total Debt

421,000

About

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.